Lipid-lowering therapy in diabetes

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.342, 2001-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Lipid-lowering agents and new onset diabetes mellitus

By Athyros Vasilios G Tziomalos Konstantinos Karagiannis Asterios Mikhailidis Dimitri P

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 1965-1970

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy

By Schöfl Christof

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 341-345

Adis International

Access to resources Recommend Favorite

National guidelines for lipid-lowering therapy unsatisfactory

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Colesevelam valuable adjunct in lipid-lowering therapy

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite